Korea University Guro Hospital has opened the Alzheimer's Prevention Center (Center Director Kang Sung-hoon).The Alzheimer's ...
NEWTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the ...
Neuroscientists believe that the presence of amyloid-beta is one of the key hallmarks of Alzheimer's. Research indicates that ...